Journal Club

 

01.09.2017

Dr. sc.nat.

David Goslings

  

Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study

Volkan Thamaz et al.

British Journal of Ophthalmology 2017, 101: 322-326

 

 

07.07.2017

Dr. med.

Judith Ries

 

Currenct perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities

Heidi Tiller et al.

International Journal of Women's Health, 2017, 9; 223-234

 

 


16.06.2017

pract. med.

Irina Franke

 

Pathophysiological Consequences And Benefits of HFE Mutations: 20 Years of Research

I. Hollerer et al.

Haematologica, May 2017, 102; 809-817

 

 

 
05.05.2017

Dr. med. vet.

Jochen Gottschalk

 

Frequency of Trypanosoma cruzi parasitemia among infected blood donors with a potential association between parasite lineage and transfusion transmission

David A. Leiby et al.

TRANSFUSION, 2017

 

 

 

07.04.2017

Dr. med.

Charlotte Engström

 

CD59: A long-known complement inhibitor has advanced to a blood group system

C. Weinstock et al

Immunohematology, 2015;31:145-151

 

 

  

17.02.2017

pract. med.

Eméry Schindler

 

Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion & (supplement)

N.M. Heddle et al

The New England Journal of Medicine, 2016;375:1937-1945

 

 

 

13.01.2017

Prof. Dr.

Reinhard Henschler

 

Exposure to ABO-nonidentical blood associated with increased in-hospital mortality in patients with group A blood

Menaka Pai et al

TRANSFUSION 2016;56:550-557

 

02.12.2016

Dr. sc. nat.

David Goslings
 

Quality of freeze-dried (lyophilized) quarantined single-donor plasma

Jürgen Bux et al

TRANSFUSION 2013;53:3203-3209


 

21.10.2016

Eduardo Meyer
 

Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants

Lukas Wisgrill et al

Cytometry Part A, 89A: 663 -672, 2016

 

 
 

02.09.2016

Dr. med. vet.

Jochen Gottschalk
 

Detection of hepatitis C virus (HCV) core-specific antibody suggests occult HCV infection among blood donors

Juan A. Quiroga et al

Transfusion, 2016;56;1883-1890

 

 

 

01.07.2016

pract. med.

Idana Feldmane

 

Climate change projections of West Nile virus infections in Europe: implications for blood safety practices

Jan C. Semenza et al

Environmental Health, 2016, 15:28

 

 

  

10.06.2016

Prof. Dr.

Reinhard Henschler

  
Targeted gene editing restores regulated CD40L function in X-linked hyper-IgM syndrome

Nicholas Hubbard et al

Blood, 2016, 127:2513-2522

 

 

 

 

20.05.2016

pract. med. 
Michael Zürcher

  

Zika Virus

Lyle R. Petersen et al

The New England Journal of Medicine, 2016;374:1552-63

 

 

 

15.04.2016

Dr. med. 
Charlotte Engström

  

Variability of Findings in Drug-Induced Immune Haemolytic Anaemia: Experience over 20 Years in a Single Centre

Beate Mayer et al

Transfusion Medicine and Hemotherapy, 2015;42:333-339

 

 

11.03.2016

pract. med. 
Young-Lan Song

  

Regular blood donation may help in the management of hypertension: an observational study on 292 blood donors

Sundrela Kamhieh-Milz et al

Transfusion, 2015

 

 

 

05.02.2016

pract. med. 
Eméry Schindler

  

What is the best strategy for the prevention of transfusion-transmitted malaria in sub-Saharan African Countries where malaria is endemic?

Jobert Richie N. Nansseu et al

Malaria Journal 2013, 12:465

 

 

 

08.01.2016

PD Dr. rer. nat.
Christoph Gassner

  

Identification of genetic polymorphisms that predict responder/non-responder profiles to the RhD Antigen

Joanne C.G. Tan et al

Molecular Immunology 2015 Dec;68:628-33

 

 

 

04.12.2015

Dr. med. vet.

Jochen Gottschalk

 

Rare transmission of hepatitis B virus by Dutch donors with occult infection

Ryanne W. Lieshout-Krikke et al

Transfusion 2015

 

 

 

06.11.2015

Dr. med.

Adriana Komarek
 

In vivo biodistribution and oxygenation potential of a new generation of oxygen carrier

Tony Le Gall et al

Transfusion 2014;187:1-9

 

 

03.10.2015

Prof. Dr. med.

Reinhard Henschler
 

Platelet pool inventory management: theory meets practice

Wim de Kort et al

Journal of Biotechnology 2011;51:2295-2303

 

04.09.2015

Eduardo Meyer
 

Evaluation of FMH QuikQuant for the Detection and Quantification of Fetomaternal Hemorrhage

Cedric Pastoret et al

Cytometry Part B (Clinical Cytometry);84B:37-43 (2013)

 

03.07.2015

Pract. med.

Young-Lan Song

 

A case for stocking O D+ red blood cells in emergency room trauma bays

Erin Meyer and Lynne Uhl

Transfusion 2015;55:791–795

 

05.06.2015

Pract. med.

Michael Zürcher

 

The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries

Sheila F. O'Brien et al.

Transfusion Medicine Reviews (2015)

 

08.05.15

Dr. pharm.

Andreas Glauser

 

Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements

Giuseppe Marano et al.

Blood Transfus DOI 10.2450/2014.0174-14

 

10.04.15

Elise Gourri

 

Digital PCR to assess haematopoietic chimaerism after allogeneic stem cell Transplantation

Tanja Stahl, Manja Böhme, Nicolaus Kröger, Boris Fehse

Experimental Hematology (2015), doi:10.1016/j.exphem.2015.02.006

 

06.03.15

Pract. med.
Ioana Vadeanu

 

Profound Morphological Changes in the Erythrocytes and Fibrin Networks of Patients with Hemochromatosis or with Hyperferritinemia, and Their Normalization by Iron Chelators and

Other Agents

Etheresia Pretorius et al.

PLOS ONE | 1 January 2014 | Volume 9 | Issue 1 | e85271 | doi:10.1371/journal.pone.0085271

 

06.02.15

PD Dr. rer. nat.
Christoph Gassner

 

Genetic Variants Regulating Immune Cell Levels in Health and Disease

Valeria Orrù et al.

Cell 155, 242–256, September 26, 2013; doi:10.1016/j.cell.2013.08.041

 

09.01.15

Pract. med.

Felicitas Martinez Leanes

 

Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected

blood donors

D. Juhl et al.

Vox Sanguinis (2014) 107, 226-232

 

5.12.14

Dr. med. vet.

Jochen Gottschalk

 

Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in Switzerland

Dorita Avila et al.

American Journal of Epidemiology (2014);179(12):1514-1525

 

14.11.14

Dr. sc. nat.

David Goslings

 

Activity-based costs of blood transfusions in surgical patients at four hospitals

Aryeh Shander et al.

Transfusion (2010), 50, 753-765

 

5.9.14

Dr. med.

Adriana Komarek

 

Health Care-Associated Infection After Red Blood Cell Transfusion:

A Systematic Review and Meta-analysis

Jeffrey M. Rohde et al.

JAMA (2014), 311(13), 1317-1326

 

11.7.14

Pract. med.

Ioana Vadeanu

 

Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia

David B. Bregman et al.

Therapeutic Advances in Hematology (2014) 5, 48-60

 

13.6.14

Pract. med.

Young-Lan Song

 

Pattern of care of blood donors with early-uncomplicated hereditary haemochromatosis in a Swiss blood donation centre

Stefashyna et al.

Vox Sanguinis (2014) 106, 111-117

 

16.5.14

Dr. med.

Judith Ries

 

How safe is safe: new human immunodeficiency virus Typ 1 variants missed by nucleid acid testing

Benjamin Müller et al.

Transfusion, Vol. 53, Oct. 2013

 

4.4.14

pract. med.

Michael Zürcher

 

Transfusion-transmitted arboviruses

L.R. Petersen et M.P. Busch

Vox Sanguinis (2010), 98; 2495-503

 

10.01.14

Dr. med.

Alexander Markovic

  

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

Thorsten Klampfl et al.

The New England Journal of Medicine, 369; 2379-2390. 

 

06.12.13

Dr. med. vet.
Jochen Gottschalk

  

Infectivity of blood products from donors with occult hepatitis B virus infection

Jean-Pierre Allain et al.

Transfusion, vol. 53, 1405-1415, published July 2013 

 

22.11.13

Dr. sc. nat.
David Goslings

  

Evaluation of the hemostatic potential including thrombin generation of three different therapeutic pathogen-reduced plasmas

M. Hacquard et al.

Vox Sanguinis (2011) 102, 354-361 

 

04.10.13

Dr. med.
Adriana Komarek

 

Selective testing for Trypanosoma cruzi: the frist year after implementation at Canadian Blood Services

Sheila F. O'Brian et al.

Transfusion, 53: 1706-1713, published August, 2013 

 

13.09.13

Dr. rer. nat.
Stefan Meyer

 

High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors

Stella T. Chou et al.

Blood, published online May 30, 2013 

 

05.07.13

Dr. med.
Claudia Schlicker

 

Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients

J.G. Perkins et al.

Transfusion, 2011; 51: 241-252 

 

07.06.13

Dr. med.
Beat M. Frey

 

A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

Simon J. Stanworth et al.

The New England Journal of Medicine, 368;19, 1771-1790.

 

Eliminate Prophylactic Platelet Transfusion?

Sherill J. Slichter etc al.

The New England Journal of Medicine, 368;19, 1837-1838. 

 

03.05.13

pract. med.
Michael Zürcher

 

Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products

Carolyn M. Millar and Mike Makris

British Journal of Haematology, 2012, 158, 442-452 

 

08.03.13

PD Dr. rer. nat.
Christoph Gassner

 

Association study identifying polymorphisms in CD47 and other extracellular matrix pathway genes as putative prognostic markers for colorectal cancer

J. Lascorz et al.
Int. J Colorectal Dis, published online, 28 July, 2012 

 

01.02.13

pract. med.

Young-Lan Song

 

Repeated short-term warming of red blood cell concentrates has minimal effect on their quality

S. Thomas, V. Hancock & R. Cardigan
Vox Sanguinis (2012), 103, 113-121 

 

07.12.12

Dr. med.

Oliver Sperisen

 

Non-0 Blood Type is the Commonest Genetic Risk Factor for VTE: Results from a Meta-Analysis of the Literature

Francesco Dentali et al.
Published online, June 27, 2012 

 

02.11.12

Dr. sc. nat.

David Goslings

 

Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy 

Jin Hyen Baek et al.
The Journal of Clinical Investigation, Vol. 122, No. 4, 1444-1458 

 

05.10.12

pract. med.

Young-Lan Song

 

Therapeutic platelett transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study

Hannes Wandt et al.
Published online, August 7, 2012 

 

31.08.12

Dr. med. vet.

Jochen Gottschalk

 

Lookback procedures after postdonation notifications during a Q fever outbreak in the Netherlands

Marian G.J. van Kraaij, Ed Slot, Boris M. Hogema, Hans L. Zaaijer
Transfusion, 2012 (published online) 

 

03.08.12

pract. med.

Michael Zürcher

 

Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH

Kazuhiko Koike and Kyoji Moriya
Journal of Gastroenterology 2005; 40:329-336 

 

06.07.12

Dr. med.

Susanna Möhn

 

Autologous serum eye drops for ocular surface disorders

G. Geerling, S. MacLennan, D. Hartwig
British Journal of Ophthalmology 2004; 88:1467-1474 

 

01.06.12

Dr. med.

Beat M. Frey

 

MYH-9 Related Platelet Disorders: Strategies for Management and Diagnosis

Karina Althaus, Andreas Greinacher
Transfusion Medicine and Hemotherapy 2010;37:260-267

 

MYH9-Related Platelet Disorders

Karina Althaus and Andreas Greinacher

Seminars in Thrombosis and Hemostasis, Vol. 35, Nr. 2, 2009

 

04.05.12

Dr. med.

Monika Albert

 

Nachweis einer arteriellen Hypertonie

A. Pechère-Bertschi, H. Stalder
PrimaryCare 2003;3:547-553

 

13.04.12

Dr. med.

Georg Schorer

 

The value of routine ferritin measurement in blood donors

Alix O'Meara et al.
Transfusion, Vol. 51, 2183-2188, October 2011

 

02.03.12

PD Dr. rer. nat.

Christoph Gassner

 

Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome 

Amy P. Hsu et al.

Blood, 8 Sept. 2011, Vol. 118, No. 10, 2653-2655

 

03.02.12

pract. med.

Micha Keil

 

Blood donors with positive direct antiglobulin tests are at increased risk for cancer

Yakir Rottenberg et al.

Transfusion, Vol. 49, 838-842, May 2009

 

02.12.11

pract. med.

Georg Schorer

 

Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project

Alberto Piperno et al.

Blood, March 2011, Vol. 117, 2953-2959

 

07.10.11

pract. med.

Micha Keil

 

Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients

Joan Cid et al.

Transfusion, Vol. 51, 1163-1169, June 2011

 

02.09.11

pract. med.

Karoline Brand-Bernhart

 

Introduction and Overview of Therapeutic Apheresis
Chidi Okafor et al.

Journal of Clinical Apheresis, 25:240-249 (2010)

 

05.08.11

Dr. sc. nat.

David Goslings

 

INTERCEPT plasma: comparability with conventional fresh-frozen plasma based on coagulation function - an in vitro analysis

J. Irsch, L. Pinkoski, L. Corash, L. Lin

Vox Sanguinis (2010) 98, 47-55

 

17.06.11

pract. med.

Michael Zürcher

 

The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro

Guillaume Deplaine et al.

Blood, 24 Feb 2011, Vol. 117, Nr. 8

 

06.05.11

Dr. med.

Silke Esser

 

Generation Y and Blood Donation: The Impact of Altruistic Help in a Darwiportunistic Scenario

Christian Scholz

Transfusion Medicine and Hemotherapy, 2010;37:195-202

 

01.04.11

Dr. med. vet.

Jochen Gottschalk

 

Quantification of viral inactivation by photochemical treatment with Amotosalen and UV A light, using a novel polymerase chain reaction inhibition method with preamplification

Allain J.P. et al.

Journal of Infectious Diseases, 2006:194, 1734-1744

 

04.03.11

Dr. pharm.

Andreas Glauser

 

Practical guidelines for applying statistical process control to blood component production

N. Beckman et al.

Transfusion Medicine, 2009, 19, 329-339

 

04.02.11

PD Dr. rer. nat.

Christoph Gassner

 

Mutations in EKLF/KLF1 from the molecular basis of the rare blood group In(Lu) phenotype

Belinda K. singleton et al.

Blood, 1 Sep 2008, Vol. 112, Nr. 5 

 

07.01.11

Dr. med.

Dubravko Sinovcic

 

Reduction in potassium concentration of stored red blood cell units using a resin filter

Chisa Yamada, Eugenie S. Heitmiller, Paul N. Ness, and Karen E. King

Transfusion 2010 Sep; 50(9):1926-33 

 

03.12.10

Dr. med.

Peter Lodemann

 

Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies

Jorge J. Castillo, Samir Dalia, and Sheila K. Pascual

Blood, 21 October 2010, Vol. 116, No 16 

 

05.11.10

pract. med.

Charlotte Engström

 

How I treat autoimmune hemolytic anemias in adults

Klaus Lechner and Ulrich Jäger

Blood, 16 Sept 2010, Vol. 116, No 11 

 

01.10.10

pract. med.

Micha Keil

 

Selection Criteria to Protect the Blood Donor in North America and Europe: Past (Dogma), Present (Evidence), and Future (Hemovigilance)

Anne Eder al al.

Transfusion Medicine Reviews, Vol. 23, No 3 (July), 2009: pp 205-220 

 

06.08.10

Dr. sc. nat.

David Goslings

 

Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies

Susanne M. Picker et al.

Transfusion, Vol. 49, November 2009, 2311-2318 

 

09.07.10

Dr. med.

Susanna Möhn

 

Clinical stem cell therapies for severe autoimmune diseases

J.A. Snowden et al.

Transfusion Medicine, 2009, 19, 223-234 

 

04.06.10

pract. med.

Michael Zürcher

 

TRALI is due to pulmonary venule damage from leucocytes with cholesterol crystal formation

H.M. Jensen

Vox Sanguinis (2010) 98, 130-137 

 

07.05.10

Dr. med.

Peter Lodemann

 

Dose of Prophylactic Platelet Transfusions and Prevention of Hemorrhage

Sherrill J. Slichter et al.

The New England Journal of Medicine, 362;7, February 18, 2010

 

09.04.10

Dr. med. vet.

Jochen Gottschalk

 

Detection of herpes simplex virus DNA in plasma of patients with primary but not with recurrent infection: implications for transfusion medicine?

D. Juhl et al.

Transfusion Medicine, 2010, 20, 38-47

 

05.03.10

Dr. pharm.

Andreas Glauser

 

Skin disinfection methods: prospective evaluation and postimplementation results

Sandra Ramirez-Arcos and Mindy Goldman

Transfusion, Volume 50, January 2010

 

A novel rapid and effective donor arm disinfection method

Carl McDonald et al.

Transfusion, Volume 50, January 2010

 

05.02.10

pract. med.

Georg Schorer

 

Iron treatment normalizes cognitive functioning in young women

Laura E Murray-Kolb and John L. Beard

Am J Clin Nutr 2007;85:778-87

 

08.01.10

Dr. med.

Peter Lodemann

 

Intravenous Hemostat: Nanotechnology to Halt Bleeding

James P. Bertram et al.

Sci Transl Med 1, 11ra22 (2009)

 

18.12.09

Dr. med.

Anelia Siderow

 

Restoration of NET formation by gene therapy in CGD controls aspergillosis

Matteo Bianchi et al.

Blood, Volume 114, Nr. 13, 24 September 2009

 

06.11.09

Dr. med. vet

Jochen Gottschalk

 

High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion

Malte Ziemann et al.

Transfusion Vol. 47, November 2007

 

02.10.09

Dr. med.

Judith Ries

 

Forging a field: the golden age of iron biology

Nancy C. Andrews

Blood 2008, 112:219-230

 

11.09.09

Dr. med.

Susanna Möhn

 

Severe events in donors after allogeneic hematopoietic stem cell donation

Joerg Halter et al.

Haematologica, 2009, 94-101

 

07.08.09

pract. med.

Charlotte Engström

 

Transfusion of platelet components prepared  with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion

Patrice Rasonglès et al.

Transfusion Vol. 49; 1083-1091, June 2009

 

03.07.09

pract. med.

Antje Enekwe

 

Blood donors with positive direct antiglobulin tests are at increased risk for cancer

Yakir Rottenberg et al.

Transfusion Vol. 49; 838-842, May 2009

 

05.06.09

Dr. sc. nat.

David Goslings

 

CNTO 530 functions as a potent EPO mimetic via unique substained effects on bone marrow proerythroblast pools

Pradeep Sathyanarayana et al.

Blood, 14 May 2009, Volume 113, Number 20

 

08.05.09

Dr. med.

Beat M. Frey

 

An introduction to chemokines and their roles in transfusion medicine

R.D. Davenport

Vox Sanguinis (2009) 96, 183-198

 

The many roles of chemokines and chemokines receptors in inflammation

Israel R. Charo et al.

N Engl J Med 2006; 354:610.21

 

03.04.09

Dr. pharm.

Andreas Glauser

 

Four parameter NAT screening by TaqScreen MPX with cobas S201 in Switzerland: validation, implementation and first experiences
A. Glauser, K. Hardegger, J. Gottschalk and B.M. Frey
ISBT, XIXth Regional Congress, Eastern Mediterranean & Europe, Cairo, Egypt, March 21-25, 2009

 

06.02.09

pract. med.
Georg Schorer

 

Effect of ascorbic acid intake on nonheme-iron absorption from a complete diet
James D. Cook and Manju B. Reddy
Am J Clin Nutr 2001; 73:93-8

 

23.01.09

Dr. med. vet.
Jochen Gottschalk

 

Babesiosis and blood transfusion: flying under the radar
D. A. Leiby
Vox Sanguinis (2006) 90, 157-165

 

07.11.08

pract. med.
Antje Enekwe

 

Evidence for the Use of Recombinant Factor VIIa in the Prevention and Treatment of Bleeding in Patients without Hemophilia
Janet Birchall et al.
Transfusion Medicine Reviews, Vol 22, No 3 (July), 2008

 

03.10.08

Dr. med.
Judith Ries

 

Recombinant human immunoglobulin (Ig)A1 and IgA2 anti-D used for detection of IgA deficiency and anti-IgA
Leif K. Nielsen and Morten H. Dziegiel
TRANSFUSION, Volume 48, September 2008

 

05.09.08

pract. med.
Charlotte Engström

 

Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients.
Jose R. Gonzalez-Porras
TRANSFUSION, Volume 48, July 2008

 

08.08.08

Dr. med.
Beat M. Frey

 

Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death
C. Natanson, et al.
JAMA, May 21, 2008, Vol. 299, No. 19

 

04.07.08

Dr. med.
A. Böhlen-Bodmer

 

Duration of Red-Cell Storage and Complications after Cardiac Surgery
Colleen Gorman Koch et al.
The New England Journal of Medicine, 358, 12, March 20, 2008

 

06.06.08

Dr. med.
Sven Peine

 

Hepatitis B virus infection and transfusion medicine: science and the occult
F. Blaine Hollinger
Transfusion, Vol. 48, May 2008

 

02.05.08

Dr. med.
Susanna Möhn

 

Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997
D.R. Norfolk et al.
British Journal of Haematology 1998, VOLUME 101, 609-617

 

04.04.08

pract. med.
Georg Schorer

 

Malaria and blood transfusion
A. D. Kitchen et al.
Vox Sanguinis (2006), 90, 77–84

 

08.02.08

Dr. med.
Anelia Siderow

 

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience
Sophie Park et al.
BLOOD, Vol. 111, Number 2, 15 January 2008: 574-582

 

04.01.08

Dr. med.
Beat M. Frey

 

Mutations of von Hippel-Lindau Tumor-Suppressor Gene and Congenital Polycythemia
Yves Pastore et al.
Am. J. Hum. Genet. 73:412–419, 2003

Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors
Victor R. Gordeuk et al.
BLOOD Volume 103, Number10,  3924-3932

 

07.12.07

pract. med.
G. Schorer

 

Current Risks of Transfusion-Transmitted Agents
Susan L. Stramer, PhD
Arch. Pathol. Lab Med. Volume 131, May 2007 (A Review)

 

02.11.07

pract. med.
Tanja Schneider

 

Eine kritische Begutachtung des «chronischen Lyme Disease» (chronischen Lyme Erkrankung)
A Critical Appraisal of “Chronic Lyme Disease”

Henry M. Feder, Jr. et al.
N Engl J Med 2007;357:1422-30

 

05.10.07

Dr. med

A. Siderow

 

Die Wertigkeit von DNA Analysen für die Antigene des Kell und Kx-Blutsystems
The value of DNA analysis for antigens of the Kell and Kx blood group systems

Soohee Lee
TRANSFUSION, VOLUME 47, July 2007 Supplement: 32S-39S

 

07.09.07

Dr. med.

O. Ochmann

 

Thema: «Ist G-CSF Leukämogen?»

Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy
Melvin H. Freedman et al.
BLOOD, VOLUME 96, NUMBER 2, 15 JULY 2000: 429 - 436

Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congential neutropenia induces premature apoptosis of differentiating promyelocytes
Pam Massullo et al.
BLOOD, VOLUME 105, NUMBER 9, 1 MAY 2005: 3397 - 3404 BLOOD, VOLUME 96, NUMBER 2, 15 JULY 2000: 429 - 436

 

03.08.07

pract. med.

G. Schorer

Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000
Reinhard A. Seger, et al. BLOOD, VOLUME 100, NUMBER 13, 15 DECEMBER 2002: 4343-4350

 

06.07.07

pract. med.

T. Schneider

 

Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study
Clarence Chant, Gail Wilson and Jan O Friedrich Crit Care Med 2006, Vol. 10, 5: R140

 

01.06.07

Dr. med.

A. Böhlen-Bodmer

 

The new Generation of Platelet Additive Solution for Storage at 22°C: Development an Current Experience
Jürgen Ringwald, Robert Zimmermann and Reinhold Eckstein Transfusion Medicine Reviews, Vol. 20, No 2 (April), 2006: pp 158-164

 

04.05.07

Dr. med

A. Siderow

 

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukaemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al, BLOOD, 2007: 109 (9): 3658 - 3666

 

13.04.07

pract. med.

G. Schorer

 

Iron Depletion by Phlebotomy Improves Insulin Resistance in Patients With Nonalcoholic Fatty Liver Disease and Hyperferritinemia: Evidence from a Case-Control Study
Luca Valenti, M.D., et al., Am J Gastroenterol 2007;102:1–8
Department of Internal Medicine, Universita’ di Milano, Ospedale Policlinico Mangiagalli Regina Elena IRCCS, Milano, Italy

 

02.03.07

Dr. sc. nat.

C. Ottiger

 

EPO in cancer anemia: Benefits and potential risks
Morgan Milanoa, Maurice Schneiderb, Critical Reviews in Oncology/Hematology, ONCH-1050; 1-7pages

 

02.02.07

Dr. med.

O. Ochmann

 

Transfusionsmedizinische Ansätze in der Behandlung von Sichelzellerkrankung und Thallasämie – classical approaches

New Approaches to the Transfusion Management of Thalassemia

Richard D. Propper et al. Blood 55: 55-60, 1980

Erythrocytapheresis Therapy to Reduce Iron Overlaod in Chronically Transfused Patient With Sickle Cell Disease

Haewon C. Kim et al. Blood 83: 1136-1142, 1994

Selective Isolation of Young Erythrocytes for Transfusion Support of Thalassemia Major Patients

Laurence Corash et al. Blood 57: 599-606, 1981

 

01.12.06

Dr. med.

O. Ochmann

 

ACE-Hemmer und Apherese. Bedeutung von ACE-Inhibitoren in der Pathogenese einer primär hypotensiven Transfusionsreaktion.

Hypotensive reactions associated with plateled transfusions and angiotensinconverting enzyme inhibitors

Mair B., Leparc G.F., Vox Sang 1998;74:27-30

Bradykinin production during donor plasmapheresis procedures

Perseghin P., Capra M., Baldini V., Sciorelli G., Vox Sang 2001;81:24-28

 

03.11.06

Dr. med.

Beat M. Frey

 

Lessons from the Wiskott-Aldrich Syndrome
Jeniffer M. Puck at al., NEJM 2006;355;17:1759-1761 space
The Genotype of the Original Wiskott Phenotype
Vera Binder at al., n NEJM 2006;355;17:1790-1793
Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia
Phil J. Ancliff et al., BLOOD. 2006;108;7:2182-2189

 

06.10.06

 

Dr. S. Khoschnewis

Iron-Deficiency Anemia: Rexamining the Nature and Magnitude of the Public Health Problem

Iron and Its Relation to Immunity and Infectious Disease

Stephen J. Oppenheimer, Green College, Oxford, UK

 

15.09.06

 

Dr. O. Ochmann

Hypercholesterinämie als kardiovaskulärer Risiskofaktor. Aktuelles follow-up der Procpective Cardiovasular Münster (PROCAM) Studie.

 

07.07.06

 

Dr. Aynur Tekin

Use of blood therapeutically drawn from hemochromatosis patients

 

02.06.06

 

Dr. E. Matheis

Rituximab for the treatment of refractory autoimmune haemolytic anemia in children

Blood, 15. May 2003, Volume 101, Number 10

 

05.05.06

 

Dr. K. Bracher

Public-Access Defibrillation and Survival after Out-of-Hospital Cardiac Arrest

New England Journal of Medicine, 2004, 351;7: 637 - 646

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Merken